{"id":"W3022359034","doi":"10.1002/hon.2437_133","title":"IBRUTINIB VS TEMSIROLIMUS: THREE‐YEAR FOLLOW‐UP OF PATIENTS WITH PREVIOUSLY TREATED MANTLE CELL LYMPHOMA FROM THE PHASE 3, INTERNATIONAL, RANDOMIZED, OPEN‐LABEL RAY STUDY","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Mantle cell lymphoma; Temsirolimus; Refractory (planetary science); Ibrutinib; Progression-free survival; Gastroenterology; Phases of clinical research; Neutropenia; Tolerability; Toxicity; Surgery; Adverse effect; Lymphoma; Chemotherapy; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001092263,0.0003208357,0.001890501,0.00006620314,0.0002957098,0.0001019541,0.001649739,0.0002896801,0.0008116254],"category_scores_gemma":[0.001822764,0.0001593348,0.0001655671,0.0001093798,0.001006321,0.0001470703,0.001010556,0.0002615131,0.0001320065],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001656907,"about_ca_system_score_gemma":0.001879671,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001960898,"about_ca_topic_score_gemma":0.000398512,"domain_scores_codex":[0.9967495,0.0005465549,0.0008335612,0.0006533283,0.0007100745,0.0005069343],"domain_scores_gemma":[0.9951048,0.002193966,0.0007547239,0.001332764,0.0003938552,0.0002198181],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6761792,0.03393851,0.2722677,0.00009490934,0.001842106,0.001560939,0.001390766,0.00000152259,0.0001019015,0.0005688004,0.006256857,0.005796762],"study_design_scores_gemma":[0.972795,0.006737283,0.0149686,0.000114621,0.00056108,0.00005203043,0.0003049526,0.001025283,0.0003941544,0.0002479643,0.002595309,0.0002037355],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9841034,0.0001458898,0.00006579013,0.0009912435,0.0002805576,0.005293955,0.00005692529,0.00004406146,0.009018178],"genre_scores_gemma":[0.9976208,0.0000815401,0.0005879513,0.0003055539,0.00008879159,0.0004276646,0.0001193602,0.00003483535,0.0007334545],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2966157,"threshold_uncertainty_score":0.8886729,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06600161204894871,"score_gpt":0.3834560218168101,"score_spread":0.3174544097678614,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}